UBS Call 221.598 DHR 20.12.2024/ CH1251052663 /
12/11/2024 21:55:19 | Var.-0.270 | Denaro- | Lettera- | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
2.210EUR | -10.89% | - Quantità in denaro: - |
- Quantità in lettera: - |
Danaher Corporation | 221.5975 USD | 20/12/2024 | Call |
GlobeNewswire
20/08
Intelligent Product Solutions Announces that Brad Carlson Joins as VP of Technology and Business Dev...
GlobeNewswire
08/03
Resilinc CEO Honored With a 2024 Pros to Know Lifetime Achievement Award from Supply & Demand Chain ...
GlobeNewswire
26/02
DANAHER ALERT: Bragar Eagel & Squire, P.C. is Investigating Danaher Corporation on Behalf of Long-Te...
GlobeNewswire
29/01
DANAHER ALERT: Bragar Eagel & Squire, P.C. is Investigating Danaher Corporation on Behalf of Long-Te...
GlobeNewswire
13/12/2023
Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase
GlobeNewswire
15/11/2023
Brady Corporation elects Board of Directors and declares regular dividend to shareholders
GlobeNewswire
14/11/2023
Lincoln Electric Appoints J. Ashley Hall as Senior Vice President, Global Procurement
GlobeNewswire
01/11/2023
Statement from Dr. Jonathan Milner on the suspension of the “Vote AGAINST” campaign
GlobeNewswire
16/10/2023
Jonathan Milner releases presentation to Abcam plc shareholders, outlining reasons to reject Danaher...
GlobeNewswire
12/10/2023
Coave Therapeutics appoints Leading World Experts to newly formed Scientific Advisory Board dedicate...
GlobeNewswire
08/10/2023
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RPT, HT, ABCM, AGE
GlobeNewswire
02/10/2023
Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer